Note: The ethical judgments on this page refer exclusively to the action — never to the person who performs it or who came into existence through it. Cf. Note on ethical judgments (German).
Somatic cell nuclear transfer places the nucleus of a body cell into a previously enucleated oocyte. It first succeeded with living offspring in 1996 with the sheep Dolly; for human cells it was shown in 2013 that embryonic stem cell lines can be derived from the resulting blastocysts.
The magisterium defines the procedure in Dignitas personae: a nucleus taken from an embryonic or somatic cell is introduced into a previously enucleated oocyte and there activated, such that it would have to develop as an embryo.
Ontological classification
- is subclass of: genetic technology (nuclear transfer)
- presupposes: an enucleated oocyte, hence egg donation
- has subclass: reproductive cloning
- has subclass: research cloning (so-called therapeutic cloning)
- has subclass: hybrid cloning — reprogramming human nuclei in animal oocytes
- has subclass: mitomeiosis
Nuclear transfer as such is not treated here as an intrinsically evil act across the board. The magisterial condemnation targets the production of genetically identical individuals; the verdict therefore attaches to the individual subclasses, not to the technique.
What the ooplasm achieves
The real yield is reprogramming: how does one bring a nucleus that spent decades as a skin cell to behave once more like the nucleus of a germ cell?
The process begins within minutes and is at first mechanical. The cytoplasm of an oocyte arrested in metaphase II exhibits high division activity, which an inserted interphase nucleus cannot withstand: its nuclear envelope breaks down, the chromatin condenses prematurely, the somatic factors are stripped from the chromatin and replaced on reassembly by factors from the oocyte cytoplasm. Notably it is the same nuclear envelope breakdown that mitomeiosis subsequently exploits for the forced reductional division.
In parallel the epigenetic marks are erased — though incompletely. Certain chromatin regions resist stubbornly. Reprogramming by the ooplasm is an overwriting with residual traces, not an erasure.
Why it took so long in humans
The obstacle was not one of principle but species-specific: human oocytes leave their arrest prematurely under micromanipulation and thereby drop out of precisely the state that carries reprogramming. The solution consisted of caffeine for stabilization during manipulation, viral envelopes for fusion rather than purely electrical methods, and an adapted activation protocol. To this was added a factor stated openly: the strongly varying quality of individual donors’ oocytes.
The same structure recurs with mitomeiosis — there too the actual obstacle was a problem of activation.
What the procedure is for
The purposes in turn:
Reproductive cloning. The original purpose and the only one that indisputably works. In real use for livestock, pets, and endangered species. For humans prohibited and not seriously pursued.
Therapeutic cloning. This was the great justification: immunologically matched stem cells for the patient. Precisely for this human nuclear transfer was made to work in 2013 — and that purpose had by then been superseded for six years. Induced pluripotent stem cells achieve the same without oocytes, without microsurgery, and without consuming embryos.
The remainder. What is left is one achievement induced pluripotent stem cells do not provide: the oocyte cytoplasm places a nucleus not in a stem cell state but in the state of an oocyte ready to divide. Whoever wants a gamete rather than a tissue cell currently has no other machine. Mitomeiosis is the wager on this remainder.
What the procedure causes
Nuclear transfer does not solve the segregation problem — it creates it. What is inserted is a diploid nucleus that has never undergone meiosis: 46 chromosomes never paired, never recombined, never sorted. Halving is nonetheless required, and no mechanism remains for it, because the responsible one lies in the germline and was skipped.
Notable is the route the field has actually taken: the successful literature on artificial gametes — living animals from stem-cell-derived germ cells — runs throughout via stem cells and not via nuclear transfer.
Ethical assessment
The assessment here follows not an authority but the ontology’s own line of justification. It proceeds in three steps. Ontological dignity is the inalienable, objective worth of the person and the sufficient ground of the Personalist Norm — the person is to be affirmed and loved for her own sake. This norm is no imposed duty but the only adequate value-response to the being of the person. It is violated in two ways: by instrumentalization, the treatment of a person as a means rather than an end, and by oblivion of the person, the affirmation of a person not for her own sake but on account of her characteristics.
What must be examined is therefore not whether a procedure is novel or unnatural, but at which points it touches persons and how it treats them.
The three points at which nuclear transfer touches persons
The oocyte donor. She is uncontestedly a person. After hormonal stimulation, tissue is surgically removed from her that the procedure uses not as her contribution but as a reaction vessel: her nuclear genome is precisely what gets removed. The charge of instrumentalization must therefore be examined carefully — not because a removal takes place (that holds for living organ donation too), but because here the person is reduced to a function whose yield serves an alien purpose and whose personal share is deliberately erased. That her genetic contribution shrinks in the result to the mitochondria reinforces the finding: she disappears from the description of a procedure of which she remains a necessary condition. That is oblivion of the person in the ontology’s precise sense — not malice, but a person dropping out of view behind her function.
The nucleus donor. A skin cell is taken from him. An intervention of small consequence; taken by itself no violation of the norm.
The entity produced. Here everything further is decided — and differently for each subclass. Where an embryo issues from the nuclear transfer, a person in the First Dimension is present: spiritual substance in a body with active potency toward the unfolding of consciousness, with a full right to life. Where such a being is produced for research and consumed, the object of the action is the production of a person for the purpose of her destruction. By the fontes moralitatis the object determines the moral species of the act — a good intention changes nothing. That is an intrinsically evil act.
Why the technique as such is not condemned
Nuclear transfer is not classified in personal ontology as an intrinsically evil act, and this is a reasoned decision, not an omission.
An intrinsically evil act is determined by its object: by what the agent knowingly and willingly does. The object of nuclear transfer is the transfer of a cell nucleus into a cell. In itself this contains no disregard of a person — the disregard enters at the three points named, and it enters there in differing degrees. To condemn the technique across the board would be to condemn it without stating the personal reference that alone can carry the condemnation. The ontology would then assert more than it can justify.
This has practical consequences: every subclass must be examined in its own right. With reproductive cloning the violation lies in disposing over another human being’s genetic characteristics; with research cloning in production for consumption; with mitomeiosis in neither, but in the presupposed egg donation and in the unresolved question of status. Whoever let the verdict be inherited would lose precisely these distinctions.
What nevertheless holds for every form
One finding strikes nuclear transfer regardless of purpose: it constitutively presupposes an enucleated oocyte and hence egg donation. The assessment therefore travels not by inheritance but along the path of presupposition — and applies even where no identical genome and no research embryo arises.
Where the ontology does not commit itself
Two things remain open. First, the status of entities that have neither arisen through fertilization nor emerged from the germline; there the precautionary principle and in dubio pro persona apply. Second, legality: it is jurisdiction-relative and not derivable from the ontology at all. In Germany producing a clone is a criminal offence, in the United Kingdom nuclear-transfer research is permitted under licence — the ontology does not decide this conflict, it records it.
The strongest objection to this assessment
One may hold the separation of technique and application too generous. Whoever does not condemn nuclear transfer as such, so the objection runs, shifts the assessment onto an intention that can be redeclared: the same laboratory procedure is called research cloning on one occasion and gamete production on another, and the entity on which it is performed is the same. And whoever makes intention the distinguishing mark has just abandoned the fontes moralitatis — there the object, not the intention, determines the moral species.
This tells. The answer must be: it is not the intention that distinguishes the cases but the object itself, and with research cloning and gamete production the object really is different — there the production of a being for consumption, here the production of a cell. Whether this answer holds depends on whether the mitomeiotically reduced cell really is not a person. And that is precisely the open question. The assessment of nuclear transfer is therefore not closed but hangs on a question of status that no one has yet posed.
Corroboration from the magisterial tradition — as confirmation, not as ground of the judgment: Dignitas personae 28 defines the procedure and condemns cloning; n. 30 applies the precautionary argument to unresolved cases. The Pontifical Academy for Life formulated in 1997 the point here treated under oblivion of the person: women are reduced to a few of their purely biological functions, namely providing ova and womb.
See also
- Mitomeiosis — the current application
- Reproductive Cloning
- In Vitro Gametogenesis — the competing route
- Oocyte, Gamete, Germline
- Meiosis, Genomic Imprinting
- Synthetic Embryo Model
- Genetic Technology, Embryo Research Utilization
- Personalist Norm
Sources: Generated by querying the Personhood ontology. Research as of 27 July 2026.
Further sources:
- Wilmut, I. et al. (1997): Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810–813.
- Tachibana, M. et al. (2013): Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 153(6): 1228–1238.
- Matoba, S. et al. (2014): Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation. Cell 159(4): 884–895.
- Takahashi, K. & Yamanaka, S. (2006): Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4): 663–676.
- Congregation for the Doctrine of the Faith (2008): Dignitas personae. Instruction on Certain Bioethical Questions.
- Pontifical Academy for Life (1997): Reflections on Cloning.